Furthermore, the angiogenic capacity of NPC cells, along with the expression of angiogenesis markers Ang-1 and VEGF, was significantly augmented in the context of HSP90B1 overexpression, with these effects being effectively counteracted in the presence of cetuximab (Figs. 4I–K). This evidence concerns the gene HSP90B1 and nasopharyngeal carcinoma.